- About
- Resource Library
- Collections
- Events
Virtual Event – Antipsychotic Treatment Options in Schizophrenia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Antipsychotic Treatment Options in Schizophrenia
The treatment of schizophrenia has evolved over the past half-century primarily in the context of antipsychotic drug development. In addition to reviewing the evolution of antipsychotic treatments for schizophrenia, in this virtual live event the speakers will discuss definitions of adherence and review possible reasons for nonadherence, as well as compare evidence supporting oral and long-acting injectable antipsychotics. Lastly, the speakers will explore potential communication strategies for clinicians to assess patient adherence and discuss alternative interventions.
Featuring
-
Martin Guerrero, MD, JD
Medical Director of Forensic Services, El Paso Psychiatric Center; Senior Examiner, American Board of Psychiatry & Neurology; Vice Chair of the Substance Abuse Task Force, American Bar Association; and the Medical Reviewer for Psychiatry, El Paso First Health Plans, Inc.
-
Jessie Chambers, PhD (OPDC)
Senior Clinical & Scientific Liaison
Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
Registration
Already registered?Already registered?
- Resource Library
